Vectorite Biomedical Inc. (TPEX:4170)

Market Cap	551.52M -3.1%
Revenue (ttm)	61.41M +6.3%
Net Income	96.17M
EPS	2.19
Shares Out	43.77M
PE Ratio	5.75
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	31,448
Open	12.35
Previous Close	12.65
Day's Range	12.10 - 12.65
52-Week Range	11.45 - 18.15
Beta	0.46
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 11, 2026

About Vectorite Biomedical

Vectorite Biomedical Inc. engages in the research and development of biotechnology in Taiwan and internationally. It is involved in cell preparation product manufacturing; and collection and storage of immune cells. The company’s products are used in the field of infectious diseases and inflammation, cancer, oncology. Vectorite Biomedical Inc. was incorporated in 2004 and is based in New Taipei City, Taiwan.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2004
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 4170

Financial Performance

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jun 19, 2026

Data Sources Report a data error